Get started
Author

Parichehr Amiri

Observed name: Amiri, Parichehr
ORCID: 0000-0003-4230-9383
Observed ORCID: 0000-0003-4230-9383
OpenAlex ID: A5086730925
Role of Butyrate, a Gut Microbiota Derived Metabolite, in Cardiovascular Diseases: A comprehensive narrative review
2022 · Parichehr Amiri, Seyed Ahmad Hosseini, et al. · Frontiers in Pharmacology · 154
PDF
Consumption of melatonin supplement improves cardiovascular disease risk factors and anthropometric indices in type 2 diabetes mellitus patients: a double-blind, randomized, placebo-controlled trial
2021 · Hadi Bazyar, Ahmad Zare Javid, et al. · Trials · 44
PDF
Mechanistic insights into the pleiotropic effects of butyrate as a potential therapeutic agent on NAFLD management: A systematic review
2022 · Parichehr Amiri, Sara Arefhosseini, et al. · Frontiers in Nutrition · 42
PDF
Inflammatory Potential of Diet: Association With Chemerin, Omentin, Lipopolysaccharide-Binding Protein, and Insulin Resistance in the Apparently Healthy Obese
2018 · Susan Mirmajidi, Azimeh Izadi, et al. · Journal of the American College of Nutrition · 34
Associations between new and old anthropometric indices with type 2 diabetes mellitus and risk of metabolic complications: a cross-sectional analytical study
2021 · Parichehr Amiri, Ahmad Zare Javid, et al. · Jornal Vascular Brasileiro · 20
PDF
The effects of sodium butyrate supplementation on the expression levels of PGC-1α, PPARα, and UCP-1 genes, serum level of GLP-1, metabolic parameters, and anthropometric indices in obese individuals on weight loss diet: a study protocol for a triple-blind, randomized, placebo-controlled clinical trial
2023 · Parichehr Amiri, Seyed Ahmad Hosseini, et al. · Trials · 18
PDF
Expression of PGC-1α, PPAR-α and UCP1 genes, metabolic and anthropometric factors in response to sodium butyrate supplementation in patients with obesity: a triple-blind, randomized placebo-controlled clinical trial
2024 · Parichehr Amiri, Seyed Ahmad Hosseini, et al. · European Journal of Clinical Nutrition · 12
PDF
Toll-like receptor signaling and serum levels of interferon β and lipopolysaccharide binding protein are related to abdominal obesity: a case-control study between metabolically healthy and metabolically unhealthy obese individuals
2018 · Mahsa Naghizadeh, Behzad Baradaran, et al. · Nutrition Research · 12
Association of endotoxaemia with serum free fatty acids in metabolically healthy and unhealthy abdominally obese individuals: a case–control study in northwest of Iran
2017 · Maryam Saghafi-Asl, Parichehr Amiri, et al. · BMJ Open · 10
PDF
Association of proinflammatory genes expression with serum interleukin 1β and free fatty acids in metabolically healthy and unhealthy abdominally obese individuals: a case-control study
2019 · Parichehr Amiri, Behzad Baradaran, et al. · BMC Immunology · 7
PDF
Expression of lipid metabolism- related genes, body composition and inflammation: Effects of sodium butyrate supplementation in subjects with obesity
2024 · Parichehr Amiri, Seyed Ahmad Hosseini, et al. · Journal of Functional Foods · 5
Insulin resistance in relation to inflammatory gene expression and metabolic features in apparently healthy obese individuals
2018 · Parichehr Amiri, Mahsa Naghizadeh, et al. · International Journal of Diabetes in Developing Countries · 2
Lipid profile in relation to inflammatory and insulin resistance markers and anthropometric indices in the apparently healthy abdominally obese
2019 · Naghizadeh, Mahsa, Saghafi-Asl, Maryam, et al. · Progress in nutrition
PDF
Abdominal obesity is a modifier of the association between physical activity and metabolic syndrome: a case-control study
2019 · Karamzad, Nahid, Saghafi-Asl, Maryam, et al. · Progress in nutrition
PDF
Association of dietary fat intake with Toll Like Receptor2 and Myeloid differentiation 88 genes expression in prepheral blood mononuclear cells and serum level of interlukin 1β in patients with metabolic syndrome
2019 · Maryam Saghafi Asl, Behzad Baradaran, et al.
Works count: 15
Citation count: 360
H-index: 9
I10-index: 9
Year
Topic
Type